S

Seegene Inc
KOSDAQ:096530

Watchlist Manager
Seegene Inc
KOSDAQ:096530
Watchlist
Price: 27 900 KRW 1.45%
Market Cap: ₩1.5T

Net Margin

-0.1%
Current
Declining
by 2.6%
vs 3-y average of 2.5%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-0.1%
=
Net Income
₩-638.7m
/
Revenue
₩458.9B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-0.1%
=
Net Income
₩-638.7m
/
Revenue
₩458.9B

Peer Comparison

Country Company Market Cap Net
Margin
KR
Seegene Inc
KOSDAQ:096530
1.5T KRW
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
393.1B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
185.9B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
172.7B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.7B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.5B USD
Loading...
AU
CSL Ltd
ASX:CSL
86.9B AUD
Loading...
NL
argenx SE
XBRU:ARGX
43.4B EUR
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...

Market Distribution

In line with most companies in Korea
Percentile
38th
Based on 2 632 companies
38th percentile
-0.1%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

Seegene Inc
Glance View

Market Cap
1.5T KRW
Industry
Biotechnology

Seegene, Inc. engages in the manufacturing and distributing of molecular diagnostics and reagents. The company is headquartered in Seoul, Seoul. The company went IPO on 2010-09-10. The firm mainly provides infectious pathogens inspection products, including allergic respiratory pathogens, sexually transmitted diseases pathogens, human papilloma virus (HPV) and other inspection products, drug resistance inspection products, single nucleotide polymorphisms (SNP) inspection products, as well as somatic mutation cancer inspection products. In addition, it is involved in the provision of automatic real-time detection instruments. The firm provides its products under the brand names of Seeplex, Anyplex and Magicplex. The firm distributes its products within domestic market and to overseas markets.

Seegene Inc Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-0.1%
=
Net Income
₩-638.7m
/
Revenue
₩458.9B
What is Seegene Inc's current Net Margin?

The current Net Margin for Seegene Inc is -0.1%, which is below its 3-year median of 2.5%.

How has Net Margin changed over time?

Over the last 3 years, Seegene Inc’s Net Margin has decreased from 30.1% to -0.1%. During this period, it reached a low of -4.9% on Dec 31, 2024 and a high of 30.1% on Sep 30, 2022.

Back to Top